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Abstract: Inflammatory myofibroblastic tumor (IMT) of the lung
is a rare tumor but it should be considered when dealing with
primary lung tumors in children, adolescents, and nonsmoking
adults. It is, from a pathologic point of view, a benign tumor
composed of a spindle cell proliferation and inflammatory cells.
Its clinical behavior, however, is variable with a benign evolution
at one, and a malignant evolution with recurrent and metastatic
disease at the other end of the spectrum. Diagnosis is very
difficult and often only possible after resection of the tumor. We
present a case of pulmonary IMT in a 15-year-old male with
malignant features on radiographic and 18F-Fluoro-deoxyglucose
positron emission tomography imaging. Pathogenesis, pathology
findings, clinical behavior, and imaging of pulmonary IMT are
briefly discussed.
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(J Thorac Oncol. 2009;4: 923–926)
CASE REPORT
A 15-year-old male patient without a relevant medical
history was referred to our institution for analysis of a large
mass in the lower lobe of the left lung. He had been asymp-
tomatic until a few weeks before admission when he experi-
enced a short period of hemoptysis. Apart from an occasional
stabbing left-sided chest pain, not related to respiration, there
were no other pulmonary manifestations. His vital signs and
physical examination were unremarkable. Laboratory inves-
tigation showed a mildly elevated C-reactive protein but was
otherwise normal.
A chest radiograph showed a mass-like consolidation
in the left lower lobe with hilar enlargement and a large
smooth calcification posterior to the heart. Pleural effusion
could not be excluded on the basis of these radiographs
(Figure 1).
Computed tomography of the chest demonstrated a
large heterogeneous mass in the left lower lobe with one large
and several smaller calcifications. There was no interface
with the lateral wall of the left ventricle, part of the left
hemidiaphragm, pleura of the oblique fissure and dorsal
pleura, and chest wall (Figure 2). There was no evidence of
metastases or lymphadenopathy. The mass had a systemic
blood supply through the left bronchial artery and two large
vessels branching from the supradiaphragmatic aorta suggest-
ing a sequestration. Angiography confirmed the systemic
blood supply and supported the diagnosis of a pulmonary
sequestration. 18F-Fluoro-deoxyglucose positron emission to-
mography scan showed a large lobulated mass with a maxi-
mum standardized uptake value of 12 and a cold retrocardial
zone corresponding with the large calcification. At bronchos-
copy there was no endobronchial component of the mass
visible, but there was compression of the lingular bronchus
and obstruction of the lower lobe bronchus caused by
the tumor.
At this stage in the work-up of the mass the differential
diagnosis was either a malignancy (pleomorphic carcinoma,
low-grade sarcoma, malignant fibrous histiocytoma) or an
intrapulmonary sequestration although these rarely contain
large calcifications. Because no definite histopathologic di-
agnosis could be obtained through either transthoracic fine
needle aspiration, lymphnode biopsies or a video assisted
thorascopy guided biopsy, an explorative thoracotomy was
performed. This showed a large vascularized, aggressive
looking tumor in the lower lobe which could not be separated
from the upper lobe, pericardium and diaphragm. Because of
these findings a lobectomy was not possible and an intraperi-
cardial pneumonectomy was performed with partial resection
of pericardium and diaphragm.
On gross pathology, a pale firm mass was noted in
the left lower lobe with a diameter of approximately 11
cm. Transsection revealed a solid central calcified nodule
of 5 cm (Figure 3). In the surrounding lung tissue, an
infiltrative process (organizing pneumonia type) and bron-
chiectasis were found. There was invasion in mediastinum
and pericardium with tumor positive margins at these sites.
Histopathology revealed a monotonous spindle cell prolif-
eration with an inflammatory component consisting of
plasma cells and small lymphoid cells (Figure 4). There
was evidence of vascular invasion but no mitotic activity
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or atypical cells were seen. Immunohistochemical investi-
gations were positive for alfa SMA and vimentine and
negative for cytokeratine stains, CD 34, anaplastic lym-
phoma kinase-1, desmine, and S100. Because of these
findings a malignant tumor such as pleomorfic carcinoma
or a sarcoma was unlikely and the process was diagnosed
as an inflammatory myofibroblastic tumor (IMT) also
known as an inflammatory pseudotumor.
DISCUSSION
IMT is a spindle cell proliferation of which the exact
etiology is still not completely understood. Different names
are used in the literature depending on the predominant cell
type encountered in the lesion; plasma cell granuloma or
tumor, xanthogranuloma, plasmacell/histiocytoma com-
plex or post inflammatory pseudotumor. Matsubara et al.1
used the term inflammatory pseudotumor and described
three subgroups also depending on the cell type most
encountered in a mass: organizing pneumonia, fibrous
histiocytoma, and lymphoplasmocytic type. In all three
types, an intraalveolar organizing inflammation was ob-
served and they hypothesized that an inflammatory
pseudotumor probably originates as organizing pneumo-
nia. In 1990, Pettinato et al.2 were among the first to use
the term IMT because the immunohistochemical features
of the spindle cells in these lesions resemble those of
myofibroblasts. Although most reports suggest an inflam-
matory pathogenesis with an exaggerated response to tis-
sue damage and subsequently pseudotumor formation,
there are reports suggesting a true neoplastic nature with clonal
chromosomal changes in chromosome 2.3,4 These changes are
found in region 2p23 with activation of the anaplastic lymphoma
kinase gene proving that at least a few IMT’s are indeed true
neoplasms rather than reactive processes.
IMT’s are relatively common primary lung tumors in
children accounting for approximately 20% of all primary
lung tumors.5 Patients are often asymptomatic but when
symptoms do occur they commonly consist of fever, cough,
pain, hemoptysis, or weight loss.
Imaging findings are nonspecific and range from benign
looking solitary peripheral lung nodules to endobronchial
nodules in the larger airways or large aggressive looking
tumors with invasion and metastases.6,7 When IMT’s present
as central masses there is often involvement of hilar struc-
tures and the mediastinum. Calcifications are unusual but are
encountered in about 15%. Lymphadenopathy is also an
uncommon finding. 18F-Fluoro-deoxyglucose positron emis-
sion tomography is not able to differentiate between an IMT
FIGURE 1. Posteroanterior chest radiograph showing a
mass-like consolidation in the left lower lobe with enlarge-
ment of the left hilum and a large smooth calcification
posterior to the heart.
FIGURE 2. Axial contrast-enhanced
computed tomography (CT) scan
shows a large heterogeneous mass
in the left lower lobe with one large
and several smaller calcifications. (A)
There is no interface with the wall
of the left ventricle (black arrow)
and pleura. (B) Coronal reconstruc-
tion demonstrating hilar and upper
lobe involvement and a large solid
central calcification corresponding
with the calcification seen on the
chest radiograph (asterisk). The
white arrow is pointing toward one
of the supplying arteries branching
from the descending aorta. S,
spleen; L, liver.
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and a malignancy because both can demonstrate increased
metabolic activity.8
Imaging, fine needle aspiration, or true cut biopsies
are often not able to distinguish between a IMT, a sarcoma,
or other low-grade malignancies. Diagnosis has proven to
be very difficult and almost only possible after resection
of the tumor. Resection and immunohistochemical inves-
tigations are essential to differentiate IMT’s from malig-
nancies such as low-grade myofibrosarcoma and other
tumors.
Treatment of IMT’s should consist of radical resec-
tion. Melloni et al. and Lee et al. demonstrated this in their
series in which they described the clinical history, imaging
characteristics, and clinical outcome in patients with IMT.
Complete resection and tumor size less than or equal to 3
cm were associated with a better survival. Overall 3-year
and 5-year survival rates were 82% and 74%, respective-
ly.9,10 The role of corticosteroids, chemo- or radiation
therapy is unclear.
CONCLUSION
An IMT is a rare lesion of the lung, but needs to be
considered when dealing with primary pulmonary tumors in
the lung in children, adolescents, and nonsmoking adults. The
true nature of this lesion remains controversial. It can reflect
an exaggerated inflammatory response to tissue damage with
subsequently pseudotumor formation but it may also be a true
neoplastic process. Diagnosis has proven to be very difficult
and often only possible after resection of the tumor and
immunohistochemical investigation. Prognosis seems to be
related to tumor size and completeness of the resection.
Incomplete resection can result in poor clinical outcome
stressing its potential malignant behavior.
We presented a case of an IMT in a symptomatic
patient with hemoptysis and thoracic pain. At the time of
surgery the differential diagnosis was either a lung seques-
tration or a malignancy. An IMT was diagnosed after resec-
tion which, unfortunately, was incomplete. At 4-year follow-
up, however, the patient was doing well and imaging showed
no metastatic or recurrent disease.
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FIGURE 3. Gross pathology left lung resection specimen.
There is a white, firm-elastic tumor (diameter 11 cm) in the
lower lobe with extension into the upper lobe (arrowheads).
The mass contains a focal calcification that correlates with
the calcification seen on the imaging studies (asterisk). Dia-
phragm and pericardial tissue can not be recognized prop-
erly in this picture. The arrow is pointing toward the upper
lobe bronchus. LUL, left upper lobe; LLL, left lower lobe.
FIGURE 4. Microscopy (hematoxylin-eosin stain, magnifica-
tion: original 200) showing a spindle cell proliferation set
in a collagenous stroma with an inflammatory component of
lymphocytes and plasma cells.
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